Partnering to Advance Innovation for Patients: Perspectives from Johnson & Johnson
June 23, 2026
28ABCDE
Type: Super Session
Focus Area:
Business Development and Investment
Join Johnson & Johnson’s John Reed, MD, PhD, Executive Vice President, Innovative Medicine, R&D, and Nauman Shah, Global Head of Business Development, for a discussion on how the company brings together discovery, development, and strategic partnerships to advance innovation where patients need it most.
Drawing on their experience across science and global deal-making, Reed and Shah will explore the forces shaping the future of biopharma—including evolving partnership models, global innovation trends, and the increasing focus on transformational science. They will share how Johnson & Johnson identifies and prioritizes opportunities in areas of high unmet need and also highlight the company’s first- and best-in-class approaches.
The conversation will also highlight how the combination of internal expertise and external collaboration helps accelerate progress and build a focused, differentiated portfolio designed to deliver lasting impact for patients.
Speakers



